Options
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Journal
The Lancet
Journal Volume
389
Journal Issue
10064
Pages
56-66
Date Issued
2017
Author(s)
Bruix J.
Qin S.
Merle P.
Granito A.
Huang Y.-H.
Bodoky G.
Pracht M.
Yokosuka O.
Rosmorduc O.
Breder V.
Gerolami R.
Masi G.
Ross P.J.
Song T.
Bronowicki J.-P.
Ollivier-Hourmand I.
Kudo M.
Llovet J.M.
Finn R.S.
LeBerre M.-A.
Baumhauer A.
Meinhardt G.
Han G.
Publisher
Lancet Publishing Group
Type
journal article